全肠外营养成人患者肠道形态与通透性改变的系统综述与 Meta 分析
Morphological and permeability changes of the intestine in patients nourished exclusively with parenteral nutrition: a systematic review and meta-analysis
一项系统综述评估了全肠外营养成人患者肠道黏膜形态与通透性的变化。研究通过检索 PubMed 和 Embase 数据库(截至 2025 年 5 月 31 日),对比 TPN 患者与口服/肠内营养患者及恢复肠内营养后的指标,重点分析肠黏膜萎缩及双糖试验结果。该研究遵循 PRISMA 指南,已注册于 PROSPERO 平台(注册号 CRD42022265814)。
Introduction
Medical nutrition therapies, such as enteral (EN) and parenteral nutrition (PN), are essential to preventing and treating malnutrition and its clinical consequences1,2,3. One of the main concerns in achieving nutritional goals is tolerance of nutritional therapies, which depends strongly on appropriate selection and timing, as well as the patient’s clinical status2,4. PN is recommended when oral intake and EN are contraindicated or insufficient1,2. However, prolonged fasting and exclusive PN delivery have been associated with alterations in the intestinal mucosa5,6.
The proper functioning and structural maintenance of the digestive tract depend closely on luminal nutrient stimulation delivered via the oral or enteral routes5,6. Animal model studies have shown that exclusive PN leads to alterations in the morphology and function of the gastrointestinal mucosa7. These models show that total PN (TPN), even when administered sufficiently, may increase intestinal epithelial cell apoptosis and intestinal villus and crypt atrophy8. Atrophy occurs in the absence of nutrients, as any nutrients absorbed through the intestinal lumen cannot be used by epithelial cells to meet their nutritional requirements5. In addition to its digestive and absorptive functions, the intestine acts as a barrier, preventing the spread of microorganisms such as bacteria and bacterial toxins from the intestinal lumen into the circulatory system and distant tissues and organs5,9. In mouse models receiving exclusive intravenous nutrition, an impaired intestinal epithelial barrier function has been observed, suggesting that this could result in increased intestinal permeability10. Possible consequences of TPN include a disruption of intestinal homeostasis and function, contributing to a systemic inflammatory response11,12, impaired tolerance to the reintroduction of oral or enteral feeding6,11,13, and PN-associated liver disease14,15,16.
We hypothesise that intestinal rest during TPN could be associated with alterations in the morphology and permeability of human gastrointestinal mucosa. This systematic review aimed to assess intestinal mucosal morphology and permeability in adult patients nourished exclusively with PN and when an oral or enteral diet is reintroduced.
Methods
Protocol and registration
A systematic review of clinical studies on intestinal mucosal morphology and permeability in patients nourished with TPN was performed. This systematic review was carried out following the recommendations stated by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)17. The protocol for this systematic review was also registered in the International Prospective Register of Systematic Reviews of the Centre for Reviews and Dissemination (PROSPERO) (registration number: CRD42022265814)18. The main outcomes of interest were intestinal morphological and permeability assessments observed in patients nourished with TPN over time, compared with those nourished orally/enterally and when oral/EN was reintroduced.
Literature search
Bibliographic searches in MEDLINE using the PubMed interface and in Embase using Ovid were performed. Searches were conducted from inception to 31 May 2025. English- and Spanish-language studies were included. This systematic review did not include posters, abstracts, book chapters, protocols, or articles published as preprints. Search terms and Medical Subject Headings (MeSH) terms used in the PubMed search are presented in Supplementary Table 1. An equivalent search strategy was used for the Embase database. In addition, the references of identified articles were manually checked to identify additional relevant studies for inclusion in the article selection process.
Selection process of studies
Studies identified through the literature search were assessed to be included in this systematic review using a two-phase process. In the initial phase, two independent reviewers (LP-C and EM-M) excluded articles if their title or abstract did not contain at least minimal relevant information related to “TPN”, “nutritional support”, and “intestinal atrophy”, “intestinal morphology”, or “intestinal permeability”. Subsequently, the full text of the remaining articles was revised in a second selection phase performed by the same two reviewers to select studies according to eligibility criteria. Studies were included if they reported data on adult patients (> 17 years) who were exclusively nourished by the parenteral route and assessed at least one of the following variables related to intestinal trophism (completely described below in the data collection section): (a) variables related to intestinal morphology and/or (b) variables related to intestinal permeability. We use the term ‘intestinal morphology’ to refer to the structure of the intestinal mucosa (e.g., villus atrophy), whereas ‘intestinal permeability’ refers specifically to measurements obtained from double sugar tests. Exclusion criteria included studies that did not provide information on patients receiving TPN and duplicate publications of the same study. In the case of duplicate articles, only the most updated or the one that reported the most relevant information for this study was included. Studies in which patients were nourished with TPN and those studies that compared patients on TPN with patients on supplementary PN (studies in which patients were incompletely nourished with enteral or oral nutrition and supplementary PN was used to provide full nutritional requirements), EN or oral nutrition were considered. A third reviewer (SM) reached a final consensus decision in case of disagreement on article selection.
Data collection and study variables
The same two reviewers (LP-C and EM-M) independently extracted pre-defined data from each selected article and transferred it to a specific datasheet. A third reviewer (SM) compared data extracted by the two reviewers and collaborated to resolve a final consensus decision for discrepancies. The following data was collected:
-
Study identification: first author and year of publication.
-
Main characteristics of the study: objective, study design, time of follow-up, and setting.
-
Main characteristics of the study sample: sociodemographic data (age and gender), level of medical care (critical care, hospitalised in a medical ward or outpatient), presence of a comparator group (patients or healthy volunteers with or without nutritional intervention), comorbidities and sample size.
-
Characteristics of study intervention: nutritional composition, method of administration and duration of nutritional support.
-
Main outcome measures included: a) characteristics of the intestinal mucosal morphology (mucosal thickness, villus height, microvillus height, crypt depth) and b) indicators of intestinal permeability (urinary lactulose/mannitol -L/M- and/or lactulose/rhamnose -L/R- ratios) and type of assessed samples (intestinal biopsies and/or urinary carbohydrate excretion). The rationale for choosing double-sugar permeability tests as the permeability measure in this study is to ensure methodological consistency and comparability across studies.
-
Quality assessments are explained below.
Quality assessment, risk of bias in individual studies and strength of the evidence
The methodological quality of each study was also assessed by the same two independent reviewers (LP-C and EM-M), and a third reviewer (SM) participated in case of disagreement. We used the checklists provided by the Joanna Briggs Institute Critical Appraisal tools19. These checklists provide a set of items that apply to a process of critique or appraisal of the included studies’ evidence. Each item stands for a study aspect that was rated as “Yes”, “No”, “Unclear”, or “Not applicable”. We rated these items as: “Yes” (= 1 point), “Unclear or No” (= 0 points) or “Not applicable”. Finally, an overall score for each study was calculated by dividing the total number of points scored by the number of applicable items and presented as a percentage. A lower score indicated a higher risk of bias. A study with a score > 75% was considered to have high-quality evidence, a score between 75 and 50% to have moderate quality, and a score < 50% to have low quality. In addition, we graded the strength of evidence across studies for each evaluated endpoint (morphological and permeability assessments) as high, moderate, low, or very low using the Grading of Recommendations Assessment, Development and Evaluation methodology (GRADE)20.
Data presentation and analysis
Data from the included studies were presented in their original format using tables and narrative descriptions. Evidence was synthesised using meta-narrative and quantitative synthesis. Results were grouped and presented in the following order: (a) variables related to intestinal mucosal morphology and (b) variables related to intestinal mucosal permeability. Groups of patients who received specific parenteral pharmaconutrients or experimental pharmacological treatments (e.g., growth hormone) aimed to enhance or preserve mucosal integrity or functionality were not considered in the analyses to reduce heterogeneity. Results with p > 0.05 or 95% confidence intervals (CI) for mean differences including 0 were considered non-significant.
Results of studies that compared the same group of patients over time or included a comparator group using the same outcome measures were quantitatively synthesised using a meta-analysis. All analyses were performed using the Review Manager V.5.4 software (Cochrane Collaboration)21. Outcome measures considered for meta-analyses were villus height, crypt depth, mucosal thickness, and microvillus height regarding morphological changes and the urinary L/M and L/R ratio values regarding intestinal permeability. The measure of effect was mean difference between groups and its 95% CI. All studies with available numerical data were included in the meta-analysis. Missing mean values or standard deviations (SD) were estimated using other data from studies (CIs or standard errors) when available, as allowed by RevMan software. Studies lacking sufficient data for such estimations were excluded from the quantitative synthesis and were described using tables and narrative. Initially, no study was excluded from quantitative data synthesis based on quality analysis scores. However, a sensitivity analysis of the meta-analyses was conducted to assess the robustness of the findings when excluding low quality (or high risk of bias) studies. Heterogeneity between study results was evaluated using the I2 statistic, and the random-effects model was used in all cases because of heterogeneity (either in results or in design characteristics). When a specific study included multiple assessments over time, we selected those that minimised heterogeneity in follow-up duration and baseline measurements between studies. Baseline values were prioritised as those closest to, and preferably preceding, the initiation of PN. Moreover, comparisons between patients nourished with TPN and those on oral/enteral diet were considered. A subgroup analysis was performed in an attempt to meta-analyse more homogeneous studies. Studies were grouped based on study population (surgical and non-surgical) and TPN duration (≤ 10 or > 10 days). A sensitivity analysis was performed using a leave-one-out approach to assess results robustness. In the case of those outcomes that could not be included in the meta-analyses, narrative descriptions and evidence tables are presented.
Results
A total of 1066 articles were identified using the described bibliographic database searches (513 through MEDLINE and 553 through Embase), and 5 additional articles were identified through subsequent reference checks. Supplementary Table 2 shows the search process using the search strategies in MEDLINE and Embase databases. 253 articles were duplicated and excluded, and 813 articles were assessed in the double-phase selection phase. By screening both the title and abstract of these articles, 775 studies were excluded in the first selection phase because they did not provide minimal relevant information on the topic. In a second selection phase, in which a full-text assessment of the remaining articles was performed, 23 articles were excluded because they did not meet eligibility criteria. Finally, 20 studies were included in this systematic review. The flow diagram presented in Fig. 1 summarises the selection of articles that were performed.
Adapted flow diagram for systematic reviews, which included searches of databases and citation searching.
Of the 20 included studies, 10 evaluated intestinal mucosal morphology, and 13 evaluated intestinal mucosal permeability. The main design characteristics of the included studies are presented in Table 1. Supplementary Table 3 shows the patient characteristics and variables related to intestinal morphology and permeability, and Supplementary Table 4 shows the main characteristics of the nutritional support, including composition and duration.
Synthesis of study findings
Intestinal morphology
Longitudinal changes during total parenteral nutrition
Five studies reported data on morphological changes in the intestinal mucosa over time when TPN was used (Table 2 and Supplementary Table 5)22,23,25,35,37. In the case of villus height values, three studies showed significant decreases23,25,37. while two other studies did not observe significant changes22,35. For crypt depth values, none of the studies showed a significant decrease22,23,25,35,37. Regarding mucosal thickness, one study revealed a significant decrease25 that was not observed in two other studies22,35. For microvillus height, one study reported a significant decrease22, whereas another found no significant changes25. Meta-analyses revealed non-significant changes over time in villus height, crypt depth and mucosal thickness values when participants were nourished with TPN (Fig. 2). Quantitative data synthesis could not be conducted for microvillus height because lack of data.
Forest plot illustrating the effect of TPN over time on Villus Height (A), Crypt Depth (B) and Mucosal Thickness (C) (μm) (paired data).
Comparison between total parenteral nutrition and other nutrition modalities
Six studies reported comparisons between groups of patients nourished with TPN and comparator groups not receiving TPN (Table 2 and Supplementary Table 6)23,24,27,28,30,41. In the case of villus height, two studies showed significantly lower values for patients receiving TPN compared to individuals with dyspepsia23,24 For crypt depth values, one study showed significantly lower values for two patients receiving TPN compared with individuals with dyspepsia24. Meta-analyses showed significantly lower values in villus height and crypt depth in patients nourished with TPN compared to healthy volunteers and patients with dyspepsia not receiving TPN (Fig. 3). Quantitative data synthesis could not be conducted for mucosal thickness and microvillus height because lack of data.
Forest plot illustrating the effect of TPN vs. non-TPN on Villus Height (A) and Crypt Depth (B) (μm) (unpaired data).
Longitudinal changes during oral or enteral reintroduction
Three studies reported data regarding morphological changes of the intestinal mucosa when an oral or enteral diet was reintroduced after TPN (Table 2 and Supplementary Table 5)22,24,25. Regarding villus height values, two out of three studies showed a significant increase after oral nutrition or EN reintroduction24,25. For crypt depth values, one out of three studies showed a significant increase in values after oral nutrition reintroduction24. For mucosal thickness, one study reported a significant increase when the EN diet was reintroduced, not observed for microvillus height25, whereas another study did not show significant changes in mucosal thickness or microvillus height22.
Subgroup analyses
Subgroup analyses based on patient type (surgical or non-surgical) or TPN duration (≤ 10 or > 10 days) were not feasible, as there was often only one study per subgroup, or two studies in which one contained data that could not be meta-analysed, or studies that included highly heterogeneous populations within the same cohort.
Sensitivity analyses
The results of the sensitivity analyses show poor robustness, as they are sensitive to the exclusion of some individual studies. Similarly, when excluding studies at high risk of bias, the same pattern was observed. The results of the sensitivity analyses are presented in Supplementary Table 9.
Heterogeneity between study designs and characteristics, the lack of consistency in their results, the low-quality assessments and the poor robustness indicate low evidence strength for study findings.
Intestinal permeability
Longitudinal changes during total parenteral nutrition
In the case of permeability changes of the intestinal mucosa when TPN was used, twelve studies were assessed (Table 3 and Supplementary Table 7)23,25,26,31,32,33,34,36,37,38,39,40. In the case of urinary L/M ratio, five studies reported significantly increased permeability23,25,32,33,37. Meta-analysis showed a significant increase in the L/M ratio over time when participants received TPN compared to values before nutritional support (Fig. 4). In the case of urinary L/R ratio, data from one study did not show significant changes for critically ill patients nourished with TPN26. Lack of data precluded quantitative synthesis performance for this outcome.
Forest plot illustrating the effect of TPN over time on Lactulose-Mannitol ratio for all participants (A), surgical patients (B) and non-surgical patients (C) (paired data).
Comparison between total parenteral nutrition and other nutrition modalities
In the case of intestinal mucosal permeability, comparing TPN with comparator groups not receiving TPN, seven studies were assessed (Table 3 and Supplementary Table 8)23,26,29,32,36,38,40. In the assessment of urinary L/M ratio, six studies compared patients receiving TPN with those receiving EN or with healthy controls23,29,32,36,38,40. Four of these studies found significantly higher urinary L/M ratio values for those nourished with TPN23,32,38,40, and one study found significantly higher values at the fourth and eighth follow-up days, but not at the fourteenth36. Meta-analysis showed significantly higher urinary L/M ratio in patients who received TPN compared to those who received an enteral diet (Fig. 5). In the case of urinary L/R ratio, one study showed significantly higher values for critically ill patients nourished with TPN compared to EN26. Lack of data precluded quantitative synthesis performance for this outcome.
Forest plot illustrating the effect of TPN vs non-TPN on Lactulose-Mannitol ratio for all participants (A), surgical patients (B) and non-surgical patients (C) (unpaired data).
Longitudinal changes during oral or enteral reintroduction
Two studies also assessed the effect of enteral diet reintroduction after TPN (Table 3 and Supplementary Table 7)25,39. One study did not find significant changes in the mean urinary L/M ratio after enteral diet reintroduction25 and the other study found significant decreases in mean urinary L/M ratios when TPN was gradually switched to EN after surgery. However, only a portion of the assessed patients achieved PN wean-off when these data were obtained39.
Subgroup analyses
A significant increase in the pooled estimate of urinary L/M ratio was observed in surgical patients (all receiving TPN for less than 10 days) compared to baseline levels before surgery. A subgroup analysis based on TPN duration was not feasible, as all studies with a duration ≤ 10 days were restricted to the surgical population (Fig. 4). In the non-surgical patient subgroup, no significant increase in the pooled urinary L/M ratio was observed compared with baseline. A secondary stratification of the non-surgical subgroup by TPN duration was not performed due to limited variability in TPN duration (all > 10 days; range 12–21 days) (Fig. 4). When subgroup analyses were performed in surgical (two studies with TPN duration less than 10 days) and non-surgical patients (two studies with TPN duration of 14 days) receiving TPN compared with those nourished with EN, the pooled estimated urinary L/M ratio was significantly higher in both groups receiving TPN (Fig. 5).
Sensitivity analyses
Sensitivity analyses indicates that the effect of TPN on intestinal permeability remained quite similar, suggesting robustness of these findings. Similarly, when excluding studies at high risk of bias, the same pattern was observed, with permeability results remaining stable. The results of the sensitivity analyses are presented in Supplementary Table 9.
Quantitative synthesis for comparisons was based on a small number of studies. Studies were heterogeneous, and sample sizes were small. Lack of consistency was observed across some study observations, and the quality ranged from low to high risk of bias, suggesting low (for comparisons and diet reintroduction) to moderate (for the effect of TPN over time) evidence strength for study findings.
Risk-of-bias analysis
Quality assessment of the included studies is presented in Table 1. Among the evaluated studies, 13 were at high risk of bias, 5 at moderate risk of bias, and 2 at low risk of bias.
Discussion
This systematic review summarises evidence on morphological and permeability changes in the intestinal mucosa of adults nourished with TPN. Regarding morphological changes, while some of the included studies reported significant differences in measurements, quantitative synthesis showed no significant changes in morphological outcomes over time when TPN was used for short periods. Quantitative synthesis showed significantly lower values in villus height and crypt depth in patients on TPN compared to healthy volunteers and patients with dyspepsia not receiving TPN. In the case of permeability changes, quantitative synthesis showed a significant increase over time in urinary L/M ratios compared to baseline values for participants on TPN. Patients on TPN also had significantly higher urinary L/M ratios compared with patients not receiving TPN.
The strength of the evidence is limited, as our findings are based on quite heterogeneous studies, with limited follow-up times and small sample sizes.
Assessment of intestinal mucosal morphology
The quantitative synthesis showed no significant changes in intestinal mucosal morphology over time when TPN was administered for short periods. However, findings from individual included studies were divergent. A critical review of available data suggested that TPN did not cause mucosal atrophy when administered for short periods42, whereas studies assessing the effects of TPN and prolonged fasting over several months tend to observe intestinal mucosal morphological changes24,43. Some authors have suggested a temporary resistance to intestinal change in individuals receiving TPN22,23,25, which precludes the extrapolation of findings from animal models that showed intestinal mucosal atrophy after short periods of enteral fasting whether receiving or not TPN30,43. Therefore, limited follow-up times in the studies included in these meta-analyses preclude extrapolating this evidence to TPN use over long periods.
The quantitative synthesis showed significantly lower villus height and crypt depth in patients on TPN compared to participants not receiving TPN. Two studies contributed especially to this finding: one comparing critically ill patients with a group of volunteers who did not receive TPN30 and the other comparing two patients affected by postoperative enterocutaneous fistula on long-term TPN with patients with dyspepsia not receiving TPN24. Therefore, differences attributed to baseline heterogeneity between the compared groups cannot be excluded, as factors other than TPN (e.g., patient phenotype, clinical status, or the presence of nutrients in the intestinal lumen) may also influence intestinal morphological change44,45. The performed analysis also cannot rule out that morphological measurement differences between TPN and non-TPN groups may be attributable to the pathophysiological state of patients rather than to the intrinsic effects of TPN. The potential advantages of oral nutrition or EN in facilitating the maintenance of intestinal integrity and functionality should also be taken into account45,46.
More research is needed to clarify the effects of TPN on intestinal mucosal morphology, the duration of TPN needed to observe such effects, and the clinical consequences.
Assessment of intestinal mucosal permeability
This study showed that L/M ratios were increased during TPN, suggesting a possible association between intestinal permeability changes and TPN. Primary data, largely derived from heterogeneous studies, suggest that this effect could be influenced by confounders. Subgroup analysis of surgical patients on TPN for less than 10 days showed a significant increase in the pooled estimate of urinary L/M ratios compared to pre-surgery baseline levels, not observed for the non-surgical subgroup. However, on comparing surgical and non-surgical patients on TPN versus EN, the pooled estimate of urinary L/M ratios was significantly higher in patients on TPN in both subgroups. These findings suggest an association between surgery, TPN, and increased intestinal permeability that could be mitigated by EN. Note, however, that conditions characterised by systemic inflammation, such as critical illness or pancreatitis, may be associated with early increased intestinal permeability36,47,48.
According to evidence-based standards, the current evidence is of moderate to low methodological quality, indicating that the above findings require further confirmation.
In vivo assessment of small bowel permeability has been widely evaluated by administering and measuring urinary saccharide excretion ratios like the L/M ratio49. We used the double sugar test as a measure of intestinal permeability, as traditionally used for TPN studies. The rationale for using double sugar tests is that they yield a comparable continuous variable corrected for extraintestinal confounding factors such as intestinal transit or renal function50,51. Methodological consistency between studies was adequate, despite differences in study sample, sugar solution delivery, urine sampling timepoints, and analytical techniques50. Although excluding other measures of permeability may lead to the omission of valuable data, the double sugar test yields more accurate and comparable effect estimates, as it reduces heterogeneity across studies.
Recent studies in patients receiving PN have focused on the clinical relevance of alterations in serum biomarkers of epithelial integrity and bacterial translocation52,53. In the case of critically ill patients, for instance, certain plasma markers of intestinal permeability (endotoxin and zonulin concentrations) have been associated with a progressively higher Nutrition Risk in Critically Ill (NUTRIC) score and a lower Onodera Prognostic Nutritional Index (OPNI) score47,54. The influence of the lipid composition of PN formulations is also a relevant focus of interest53,55. PN formulations are heterogeneous, particularly regarding lipid composition, and this may influence inflammatory and metabolic responses, as shown in previous reviews of fish oil–containing lipid emulsions55. For instance, a prospective study performed in patients with type 2 diabetes mellitus receiving PN concluded that formulas with lipid emulsions based on medium- and long-chain triglycerides (MCT/LCT) were associated with higher proinflammatory, prooxidative, and intestinal permeability biomarkers, compared to formulas with omega-3 polyunsaturated fatty acids (n-3 PUFA), and olive oil-based lipid emulsions. The n-3 PUFA formulas showed the most favourable effects on these measurements53.
Subgroup analyses based on PN composition were not possible due to heterogeneity across the included studies and a lack of relevant data.
Study strengths and limitations
To the best of our knowledge, this is the first systematic review and meta-analysis that explores all available evidence on morphological and permeability changes in the intestinal mucosa of adults nourished with TPN. Our findings could support the design of further studies assessing feeding intolerance and associated clinical complications, improving our understanding and management strategies for patients on TPN for prolonged periods or during severe illness56. Evidence regarding the impact of TPN on patients’ intestinal mucosa and the consequences, such as reduced tolerance to enteral or oral nutrition upon reintroduction, remains controversial57. All of these factors could potentially influence prognoses and clinical outcomes.
The main limitation of this study is the notable heterogeneity between the studies included in the meta-analysis (e.g. methodologies, participants, and follow-up periods). The level of scientific evidence across studies was low to moderate, so the results should be interpreted with care, due to the potential risk of bias arising from the fact that the included studies were substantially heterogeneous and inconclusive, with small sample sizes and short follow-up periods. Another important limitation is that this study did not differentiate between TPN characteristics (e.g., macro- and micronutrient composition, lipid-emulsion composition or the percentage of nutritional requirements covered). Moreover, the articles on intestinal permeability were limited to those that used double sugar tests, which may have excluded relevant literature. Finally, the limited follow-up duration of the included studies restricts conclusions to short-term observations, and limited variability in TPN duration precluded subgroup analyses; for instance, since all short-term TPN studies (< 10 days) were concentrated within the surgical subgroup, variables are confounded.
Conclusion
This systematic review comprehensively assesses the available evidence on morphological and permeability changes in the intestinal mucosa of adults receiving TPN. Overall evidence strength was low to moderate. No short-term changes over time were observed in intestinal mucosal morphology, although differences were observed in villus height and crypt depth on comparing TPN and non-TPN groups. Regarding intestinal permeability, urinary L/M ratios over time were observed to increase with TPN, and higher urinary L/M ratios compared to EN. While our findings point to a potential association between TPN and intestinal mucosal morphology and permeability changes, this effect could be confounded by other clinical conditions such as surgery or inflammation. Noteworthy is the lack of studies reporting data on morphological and permeability assessments after long-term TPN use. Further high-quality research is needed to determine whether morphological and permeability changes could have clinical significance, for instance, when EN or oral diet is introduced after TPN feeding, and also to clarify the possible effects of TPN duration and composition.
Data availability
All data generated or analysed during this study are included in this published article [and its supplementary information files].
References
Compher, C. et al. Guidelines for the provision of nutrition support therapy in the adult critically ill patient: The American Society for Parenteral and Enteral Nutrition. J. Parenter. Enter. Nutr. 46(1), 12–41 (2022).
Berger, M. M. Nutrition and Micronutrient Therapy in Critical Illness Should Be Individualized. J. Parenter. Enter. Nutr. 44(8), 1380–1387 (2020).
Lew, C. C. H. et al. Association between malnutrition and clinical outcomes in the intensive care unit: A systematic review. J. Parenter. Enter. Nutr. 41(5), 744–758 (2017).
Yébenes, J. C. et al. Nutritrauma: A key concept for minimising the harmful effects of the administration of medical nutrition therapy. Nutrients 11(8), 1775 (2019).
Schörghuber, M. & Fruhwald, S. Effects of enteral nutrition on gastrointestinal function in patients who are critically ill. Lancet Gastroenterol. Hepatol. 3(4), 281–287 (2018).
Guglielmi, F. W. et al. Total parenteral nutrition-related gastroenterological complications. Dig. Liver Dis. 38(9), 623–642 (2006).
Hughes, C. A. & Dowling, R. H. Speed of onset of adaptive mucosal hypoplasia and hypofunction in the intestine of parenterally fed rats. Clin. Sci. 59(5), 317–327 (1980).
Sun, X., Spencer, A. U., Yang, H., Haxhija, E. Q. & Teitelbaum, D. H. Impact of caloric intake on parenteral nutrition-associated intestinal morphology and mucosal barrier function. J. Parenter. Enteral Nutr. 30(6), 474–479 (2006).
Bischoff, S. C. et al. Intestinal permeability - a new target for disease prevention and therapy. BMC Gastroenterol. 14, 189 (2014).
Demehri, F. R. et al. Tight junction ultrastructure alterations in a mouse model of enteral nutrient deprivation. Dig. Dis. Sci. 61(6), 1524–1533 (2016).
Kwon, O., Han, T. S. & Son, M. Y. Intestinal Morphogenesis in Development, Regeneration, and Disease: The Potential Utility of Intestinal Organoids for Studying Compartmentalization of the Crypt-Villus Structure. Front Cell Dev Biol. 8, 593969 (2020).
Covello, C. et al. Parenteral nutrition, inflammatory bowel disease, and gut barrier: An intricate plot. Nutrients 16(14), 2288 (2024).
Fuentes Padilla, P. et al. Early enteral nutrition (within 48 hours) versus delayed enteral nutrition (after 48 hours) with or without supplemental parenteral nutrition in critically ill adults. Cochrane Database Syst. Rev. 10, CD012340 (2019).
Madnawat, H. et al. Mechanisms of parenteral nutrition-associated liver and gut injury. Nutr. Clin. Pract. 35(1), 63–71 (2020).
Cahova, M., Bratova, M. & Wohl, P. Parenteral nutrition-associated liver disease: The role of the gut microbiota. Nutrients 9(9), 987 (2017).
Mignini, I. et al. Intestinal-failure-associated liver disease: Beyond parenteral nutrition. Biomolecules 15(3), 388 (2025).
Page, M. J. et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 372, n71 (2021).
Pérez-Cordón L, Molina-Montes E, Yébenes JC, Campins L. Morphological and functional changes of the intestine in patients nourished exclusively with parenteral nutrition: a protocol for systematic review and meta-analysis. PROSPERO. 2022.
Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic reviews of etiology and risk. Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis. JBI; 2020. Available from: https://doi.org/10.46658/JBIMES-20-08.
Guyatt, G. et al. GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. J. Clin. Epidemiol. 64(4), 383–394 (2011).
Review Manager (RevMan). Version 5.4. The Cochrane Collaboration, 2020.
Guedon, C. et al. Decreased brush border hydrolase activities without gross morphologic changes in human intestinal mucosa after prolonged total parenteral nutrition of adults. Gastroenterology 90(2), 373–378 (1986).
Van der Hulst, R. R. et al. Glutamine and the preservation of gut integrity. Lancet 341(8857), 1363–1365 (1993).
Pironi, L. et al. Morphologic and cytoproliferative patterns of duodenal mucosa in two patients after long-term total parenteral nutrition: Changes with oral refeeding and relation to intestinal resection. J. Parenter. Enter. Nutr. 18(4), 351–354 (1994).
Buchman, A. L. et al. Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. J. Parenter. Enteral Nutr. 19(6), 453–460 (1995).
Hadfield, R. J., Sinclair, D. G., Houldsworth, P. E. & Evans, T. W. Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill. Am. J. Respir. Crit. Care Med. 152(5 I), 1545–1548 (1995).
Sedman, P. C., Macfie, J., Palmer, M. D., Mitchell, C. J. & Sagar, P. M. Preoperative total parenteral nutrition is not associated with mucosal atrophy or bacterial translocation in humans. Br. J. Surg. 82(12), 1663–1667 (1995).
Groos, S., Hunefeld, G. & Luciano, L. Parenteral versus enteral nutrition: morphological changes in human adult intestinal mucosa. J Submicrosc Cytol Pathol. 28(1), 61–74 (1996).
Reynolds, J. V. et al. Does the route of feeding modify gut barrier function and clinical outcome in patients after major upper gastrointestinal surgery. J. Parenter. Enter. Nutr. 21(4), 196–201 (1997).
Hernandez, G. et al. Gut mucosal atrophy after a short enteral fasting period in critically ill patients. J. Crit. Care 14(2), 73–77 (1999).
Jiang ZM, Cao JD, Zhu XG, Zhao WX, Yu JC, Ma EL, et al. The impact of alanyl-glutamine on clinical safety, nitrogen balance, intestinal permeability, and clinical outcome in postoperative patients: A randomized, double-blind, controlled study of 120 patients. Journal of Parenteral and Enteral Nutrition. 23(5_suppl):S62–6. (1999)
Jiang, X. H., Li, N. & Li, J. S. Intestinal permeability in patients after surgical trauma and effect of enteral nutrition versus parenteral nutrition. World J Gastroenterol. 9(8), 1878–1880 (2003).
Liu, W. et al. Impact of perioperative treatment of recombinant human growth hormone on cell immune function and intestinal barrier function: Randomized, double-blind, controlled trial. World J. Surg. 27(4), 412–415 (2003).
Zhao, G., Wang, C. Y., Wang, F. & Xiong, J. X. Clinical study on nutrition support in patients with severe acute pancreatitis. World J. Gastroenterol. 9(9), 2105–2108 (2003).
Hulsewé, K. W. et al. Does glutamine-enriched parenteral nutrition really affect intestinal morphology and gut permeability?. Clin. Nutr. 23(5), 1217–1225 (2004).
Chen, Z., Wang, S., Yu, B. & Li, A. A comparison study between early enteral nutrition and parenteral nutrition in severe burn patients. Burns 33(6), 708–712 (2007).
Tang, Z. F., Ling, Y. B., Lin, N., Hao, Z. & Xu, R. Y. Glutamine and recombinant human growth hormone protect intestinal barrier function following portal hypertension surgery. World J Gastroenterol. 13(15), 2223–2228 (2007).
Li, G. et al. The effect of early enteral nutrition on hyperthermic intraoperative intraperitoneal chemotherapy-induced mucosal permeability following gastrectomy. JPEN J. Parenter. Enteral Nutr. 36(2), 213–218 (2012).
Yao, D. et al. Perioperative Alanyl-Glutamine-Supplemented Parenteral Nutrition in Chronic Radiation Enteritis Patients with Surgical Intestinal Obstruction: A Prospective, Randomized. Controlled Study. Nutrition in Clinical Practice. 31(2), 250–256 (2016).
Shen, Q. X., Xu, G. X. & Shen, M. H. Effect of early enteral nutrition (EN) on endotoxin in serum and intestinal permeability in patients with severe acute pancreatitis. Eur Rev Med Pharmacol Sci. 21(11), 2764–2768 (2017).
Hu, Q. et al. Early enteral nutrition preserves intestinal barrier function through reducing the formation of neutrophil extracellular traps (NETs) in critically ill surgical patients. Oxid. Med. Cell. Longev. https://doi.org/10.1155/2020/8815655 (2020).
Jeejeebhoy, K. N. Enteral and parenteral nutrition: Evidence-based approach. Proc. Nutr. Soc. 60(3), 399–402 (2001).
Rossi, T. M., Lee, P. C., Young, C. & Tjota, A. Small intestinal mucosa changes, including epithelial cell proliferative activity, of children receiving total parenteral nutrition (TPN). Dig. Dis. Sci. 38(9), 1608–1613 (1993).
Serra, S. & Jani, P. A. An approach to duodenal biopsies. J. Clin. Pathol. 59(11), 1133–1150 (2006).
Kudsk, K. A. Importance of enteral feeding in maintaining gut integrity. Tech. Gastrointest. Endosc. 3(1), 2–8 (2001).
Reta-Pérez, O. et al. Trophic nutrition in ICU patients undergoing high-flow oxygen therapy and/or noninvasive mechanical ventilation: The Nutri-Trophic study. Nutrients 16(9), 1366 (2024).
Eslamian, G., Ardehali, S. H. & Vahdat, S. Z. Association of intestinal permeability with a NUTRIC score in critically ill patients. Nutrition 63–64, 1–8 (2019).
Camilleri, M., Madsen, K., Spiller, R., Greenwood-Van Meerveld, B. & Verne, G. N. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol. Motil. 24(6), 503–512 (2012).
Schoultz, I. & Keita, Å. V. The intestinal barrier and current techniques for the assessment of gut permeability. Cells 9(8), 1909 (2020).
Musa, M. A. et al. Measurement of intestinal permeability using lactulose and mannitol with conventional five hours and shortened two hours urine collection by two different methods: HPAE-PAD and LC-MSMS. PLoS ONE 14(8), e0220397 (2019).
Gan, J. et al. A case for improved assessment of gut permeability: A meta-analysis quantifying the lactulose:mannitol ratio in coeliac and Crohn’s disease. BMC Gastroenterol. 22(1), 16 (2022).
Cinkajzlová, A. et al. Increased intestinal permeability in patients with short bowel syndrome is not affected by parenteral nutrition. Physiol. Res. 68(5), 817–825 (2019).
Soria-Utrilla, V. et al. Biomarkers of oxidation, inflammation and intestinal permeability in persons with diabetes mellitus with parenteral nutrition: A multicenter randomized trial. Clin. Nutr. 44, 155–164 (2025).
Ardehali, S. H., Eslamian, G. & Malek, S. Associations between systemic inflammation and intestinal permeability with Onodera’s prognostic nutritional index in critically ill patients. Acute Crit. Care 36(4), 361–368 (2021).
Mohamed Elfadil, O. et al. New uses for a new oil: clinical applications of fish oil lipid emulsion. Curr Surg Rep. 8(8), 16 (2020).
Pérez-Cordón, L., Yébenes, J. C., Martínez de Lagrán, I. & Campins, L. Transition from total parenteral nutrition to enteral nutrition in critically ill patients in Spain: A national survey. Medicina Intensiva (English Edition) 46(8), 475–477 (2022).
Virani, F. R. et al. Incidence and effects of feeding intolerance in trauma patients. J. Parenter. Enteral Nutr. 43(6), 742–749 (2019).
Acknowledgements
Acknowledgements: We would like to thank Agustí Viladot, member of the Mataró University Hospital library service, for his assistance with the search strategy. We would also like to thank Stephanie Riera for her valuable support with the meta-analyses. This work was conducted within the framework of a doctoral thesis in medicine from the Medicine Department of the Autonomous University of Barcelona.
Funding
This study received a grant from the Spanish Society of Hospital Pharmacy (Sociedad Española de Farmacia Hospitalaria, SEFH) under the " Call for Doctoral Grants" (Convocatoria de las Ayudas al Doctorado).
Author information
Authors and Affiliations
Department of Medicine, Autonomous University of Barcelona (UAB), Bellaterra, Spain
Laia Pérez-Cordón
Department of Pharmacy, Mataró University Hospital, Mataró, Spain
Laia Pérez-Cordón
Department of Nutrition and Food Science, University of Granada, Granada, Spain
Esther Molina-Montes
Institute of Nutrition and Food Technology (INYTA) José Mataix, Biomedical Research Centre, University of Granada, Granada, Spain
Esther Molina-Montes
Instituto de Investigación Biosanitaria ibs.Granada, Granada, Spain
Esther Molina-Montes
CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain
Esther Molina-Montes
Research Unit, Mataró University Hospital, Mataró, Spain
Mateu Serra-Prat
CIBER Liver and Digestive Diseases (CIBEREHD), ISCIII, Madrid, Spain
Mateu Serra-Prat
Department of Intensive Care Unit, Mataró University Hospital, Mataró, Spain
Juan Carlos Yébenes
Department of Pharmacy, Josep Trueta University Hospital, Girona, Spain
Lluis Campins
Department of Pharmacy, Germans Trias i Pujol University Hospital, Badalona, Spain
Sergio Marin
Authors
- Laia Pérez-Cordón
- Esther Molina-Montes
- Mateu Serra-Prat
- Juan Carlos Yébenes
- Lluis Campins
- Sergio Marin
Contributions
J C Y, L C, L P C: designed of the work; E M M, L P C, S M: conducted research; E M M, L P C, M S P: analyzed data; E M M, L P C, M S P, S M: wrote paper; J C Y, L C: revised paper. All authors have read and approved the final manuscript.
Corresponding author
Correspondence to Laia Pérez-Cordón.
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Pérez-Cordón, L., Molina-Montes, E., Serra-Prat, M. et al. Morphological and permeability changes of the intestine in patients nourished exclusively with parenteral nutrition: a systematic review and meta-analysis. Sci Rep 16, 34033 (2026). https://doi.org/10.1038/s41598-026-61675-4
Received: 22 September 2025
Accepted: 07 July 2026
Published: 26 October 2026
Version of record: 26 October 2026
DOI: https://doi.org/10.1038/s41598-026-61675-4
Keywords
来源:Nature 健康护理主题 · nature.com